Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases

Abstract

In a retrospective cohort study of patients with IBD, we found vedolizumab to be well tolerated with an overall favorable safety profile. Active smoking and concomitant use of immunosuppressive agents were independently associated with infections.